PHILADELPHIA TRUST CO - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 66 filers reported holding HUMACYTE INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
PHILADELPHIA TRUST CO ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$290.0%10,0000.0%0.00%0.0%
Q2 2023$29
-6.5%
10,0000.0%0.00%0.0%
Q1 2023$31
+47.6%
10,0000.0%0.00%
+50.0%
Q4 2022$21
-99.9%
10,0000.0%0.00%
-50.0%
Q3 2022$33,000
+3.1%
10,0000.0%0.00%
+33.3%
Q2 2022$32,000
-54.9%
10,0000.0%0.00%
-50.0%
Q1 2022$71,000
-2.7%
10,0000.0%0.01%
+20.0%
Q4 2021$73,000
-58.0%
10,000
-33.3%
0.01%
-61.5%
Q3 2021$174,00015,0000.01%
Other shareholders
HUMACYTE INC shareholders Q4 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders